GPB Scientific, Inc.
Richmond, VA · CIK 0001614077 · Medtech · Private
Curate Cell Processing System using deterministic lateral displacement microfluidics to enrich leukocytes for CAR-T cell therapy manufacturing
gpbscientific.com →- Grants
- $5.4M
- 6 awards
- Sector median: 1
- Raised
- $41M
- 9 Form D · Sep 2022
- 48 months since last filing
- Contracts
- $164K
- 2 awards · Health and Human S
- #475 of 4531 in medtech
- Patents
- 23
- 0 granted · 23 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,006,911 | |
| Federal grant | Department of Health and Human Services · Phase II · Microfluidic Processing of Leukocytes for Molecular Diagnostic Testing | $1,434,795 | |
| Private capital raised | Form D · SEC | $110,000 | |
| Private capital raised | Form D · SEC | $1,372,444 | |
| Federal grant | Department of Health and Human Services · Phase II · Microfluidic Processing of Leukocytes for Molecular Diagnostic Testing | $695,269 | |
| Private capital raised | Form D · SEC | $810,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Microfluidic CAR-T Cell Processing Device | $279,969 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Microfluidic CAR-T Cell Processing Device | $1,837,939 | |
| Private capital raised | Form D · SEC | $1,500,000 | |
| Private capital raised | Form D · SEC | $15,500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Microfluidic CAR-T Cell Processing Device | $913,556 | |
| Private capital raised | Form D · SEC | $17,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Regulatory Readiness for a Superior Microfluidic CAR-T Therapy Cell Processing System | $250,000 | |
| Private capital raised | Form D · SEC | $3,600,000 | |
| Federal contract | Department of Health and Human Services · Curate System | $140,448 | |
| Federal contract | Department of Health and Human Services · Curate Cassette Kits | $23,905 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 472 | Gold Standard Diagnostics Corp. | $167K | $2.5M |
| 473 | CMP Scientific Corp | $167K | $300K |
| 474 | IONICSCALE LLC | $166K | — |
| 475 | GPB Scientific, Inc. | $164K | $41M |
| 476 | iRhythm Technologies, Inc. | $163K | $59M |
| 477 | Coalesenz Inc. | $163K | — |
| 478 | ProNova Solutions, LLC | $161K | $40M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Michael GrishamExecutive Officer
Patents
- Prevention Of Platelet Activation And Cell Differentiation During The Processing Of Blood And Blood-related Compositionsapplication
- Methods For Producing Cell Populations With Increased Nucleic Acid Uptakeapplication
- Ordered Processing Of Blood Products To Produce Therapeutically Active Cellsapplication
- Methods For Producing Cell Populations With Increased Nucleic Acid Uptakeapplication
- Methods For Producing Cell Populations With Increased Nucleic Acid Uptakeapplication
- Methods For Producing Cell Populations With Increased Nucleic Acid Uptakeapplication
- Systems And Methods For Particle Separation And Concentrationapplication
- Methods For Producing Cell Populations With Increased Nucleic Acid Uptakeapplication
- Systems And Methods For Particle Separation And Concentrationapplication
- Systems And Methods For Particle Separation And Concentrationapplication
- Prevention Of Platelet Activation And Cell Differentiation During The Processing Of Blood And Blood-related Compositionsapplication
- Microfluidic Cartridges For Processing Particles And Cellsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.